Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of SHR0532 in Healthy Subjects
NCT03645278Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in hypertension (HTN) comparing SHR0532 Arm with Placebo Arm (2 arms). Primary endpoint: Number of subjects with adverse events and serious adverse events. Status: unknown.
02
Drugs
SHR0532
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03645278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645278.